209 related articles for article (PubMed ID: 23271955)
1. Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase.
Larion M; Salinas RK; Bruschweiler-Li L; Miller BG; Brüschweiler R
PLoS Biol; 2012; 10(12):e1001452. PubMed ID: 23271955
[TBL] [Abstract][Full Text] [Related]
2. Dual allosteric activation mechanisms in monomeric human glucokinase.
Whittington AC; Larion M; Bowler JM; Ramsey KM; Brüschweiler R; Miller BG
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11553-8. PubMed ID: 26283387
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Origins of Enzyme Activation in Human Glucokinase Variants Associated with Congenital Hyperinsulinism.
Sternisha SM; Liu P; Marshall AG; Miller BG
Biochemistry; 2018 Mar; 57(10):1632-1639. PubMed ID: 29425029
[TBL] [Abstract][Full Text] [Related]
4. Homotropic allosteric regulation in monomeric mammalian glucokinase.
Larion M; Miller BG
Arch Biochem Biophys; 2012 Mar; 519(2):103-11. PubMed ID: 22107947
[TBL] [Abstract][Full Text] [Related]
5. Role of connecting loop I in catalysis and allosteric regulation of human glucokinase.
Martinez JA; Larion M; Conejo MS; Porter CM; Miller BG
Protein Sci; 2014 Jul; 23(7):915-22. PubMed ID: 24723372
[TBL] [Abstract][Full Text] [Related]
6. Kinetic Cooperativity in Human Pancreatic Glucokinase Originates from Millisecond Dynamics of the Small Domain.
Larion M; Hansen AL; Zhang F; Bruschweiler-Li L; Tugarinov V; Miller BG; Brüschweiler R
Angew Chem Int Ed Engl; 2015 Jul; 54(28):8129-32. PubMed ID: 26013420
[TBL] [Abstract][Full Text] [Related]
7. Nitric Oxide Activates β-Cell Glucokinase by Promoting Formation of the "Glucose-Activated" State.
Seckinger KM; Rao VP; Snell NE; Mancini AE; Markwardt ML; Rizzo MA
Biochemistry; 2018 Aug; 57(34):5136-5144. PubMed ID: 30053375
[TBL] [Abstract][Full Text] [Related]
8. First evidence of changes in enzyme kinetics and stability of glucokinase affected by somatic cancer-associated variations.
Těšínský M; Šimčíková D; Heneberg P
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):213-218. PubMed ID: 30590153
[TBL] [Abstract][Full Text] [Related]
9. Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease.
Sternisha SM; Whittington AC; Martinez Fiesco JA; Porter C; McCray MM; Logan T; Olivieri C; Veglia G; Steinbach PJ; Miller BG
Biophys J; 2020 Mar; 118(5):1109-1118. PubMed ID: 32023434
[TBL] [Abstract][Full Text] [Related]
10. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.
Kamata K; Mitsuya M; Nishimura T; Eiki J; Nagata Y
Structure; 2004 Mar; 12(3):429-38. PubMed ID: 15016359
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular regulation of human glucokinase.
Sternisha SM; Miller BG
Arch Biochem Biophys; 2019 Mar; 663():199-213. PubMed ID: 30641049
[TBL] [Abstract][Full Text] [Related]
13. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
14. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
15. Multiscale enhanced sampling of glucokinase: Regulation of the enzymatic reaction via a large scale domain motion.
Moritsugu K; Terada T; Kokubo H; Endo S; Tanaka T; Kidera A
J Chem Phys; 2018 Aug; 149(7):072314. PubMed ID: 30134720
[TBL] [Abstract][Full Text] [Related]
16. 23-Residue C-terminal alpha-helix governs kinetic cooperativity in monomeric human glucokinase.
Larion M; Miller BG
Biochemistry; 2009 Jul; 48(26):6157-65. PubMed ID: 19473033
[TBL] [Abstract][Full Text] [Related]
17. The active conformation of human glucokinase is not altered by allosteric activators.
Petit P; Antoine M; Ferry G; Boutin JA; Lagarde A; Gluais L; Vincentelli R; Vuillard L
Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):929-35. PubMed ID: 22101819
[TBL] [Abstract][Full Text] [Related]
18. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
19. Determinants of human glucokinase activation and implications for small molecule allosteric control.
Li Q; Gakhar L; Ashley Spies M
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1902-1912. PubMed ID: 29885360
[TBL] [Abstract][Full Text] [Related]
20. Conformational heterogeneity and intrinsic disorder in enzyme regulation: Glucokinase as a case study.
Larion M; Miller B; Brüschweiler R
Intrinsically Disord Proteins; 2015; 3(1):e1011008. PubMed ID: 28232887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
